TaggedH1Reactivation of tuberculosis after immunomodulatory treatment for severe SARS-CoV-2 infection

[1]  K. DeGeorge,et al.  Reactivation of latent tuberculosis in a COVID-19 patient on corticosteroid treatment , 2022, BMJ Case Reports.

[2]  Peter J. Godolphin,et al.  Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. , 2021, JAMA.

[3]  S. Subbian,et al.  Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis , 2021, International journal of molecular sciences.

[4]  P. Klenerman,et al.  Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era , 2021, Frontiers in Medicine.

[5]  M. Khayat,et al.  COVID-19 promoting the development of active tuberculosis in a patient with latent tuberculosis infection: A case report , 2021, Respiratory Medicine Case Reports.

[6]  M. Mantero,et al.  Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy , 2020, Respiratory Medicine.

[7]  Arthur S Slutsky,et al.  Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. , 2020, JAMA.

[8]  S. Tavakolpour,et al.  Lymphopenia during the COVID-19 infection: What it shows and what can be learned , 2020, Immunology Letters.

[9]  R. Pranata,et al.  Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis , 2020, Journal of Intensive Care.

[10]  J. Yim,et al.  Use of inhaled corticosteroids and the risk of tuberculosis , 2013, Thorax.

[11]  C. K. Kwan,et al.  HIV and Tuberculosis: a Deadly Human Syndemic , 2011, Clinical Microbiology Reviews.

[12]  F. Cobelens,et al.  LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement , 2009, European Respiratory Journal.

[13]  Mahboob Rahman,et al.  Glucocorticoid use, other associated factors, and the risk of tuberculosis. , 2006, Arthritis and rheumatism.

[14]  P. Grenier,et al.  Pulmonary tuberculosis: comparison of CT findings in HIV-seropositive and HIV-seronegative patients. , 1996, Radiology.